- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of General Electric Medical Systems--2002
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of General Electric Medical Systems--2002 will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The General Electric Medical Systems--2002 VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The General Electric Medical Systems--2002 VRIO Analysis shows that the financial resources of General Electric Medical Systems--2002 are highly valuable as these help in investing into external opportunities that arise. These also help General Electric Medical Systems--2002 in combating external threats.
- According to the VRIO Analysis of General Electric Medical Systems--2002, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The General Electric Medical Systems--2002 VRIO Analysis shows that General Electric Medical Systems--2002's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of General Electric Medical Systems--2002's products.
- According to the VRIO Analysis of General Electric Medical Systems--2002, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for General Electric Medical Systems--2002. These patents also provide General Electric Medical Systems--2002 with licensing revenue when it licenses these patents out to other manufacturers.
- The General Electric Medical Systems--2002 VRIO Analysis shows that General Electric Medical Systems--2002’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for General Electric Medical Systems--2002. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of General Electric Medical Systems--2002, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The General Electric Medical Systems--2002 VRIO Analysis shows that the research and development at General Electric Medical Systems--2002 is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for General Electric Medical Systems--2002. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of General Electric Medical Systems--2002 are found to be rare according to the VRIO Analysis of General Electric Medical Systems--2002. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by General Electric Medical Systems--2002 VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as General Electric Medical Systems--2002 and inhibit competitive advantage. This means that the local food products result in competitive parity for General Electric Medical Systems--2002. As this resource is valuable, General Electric Medical Systems--2002 can still make use of this resource.
- The employees of General Electric Medical Systems--2002 are a rare resource as identified by the VRIO Analysis of General Electric Medical Systems--2002. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of General Electric Medical Systems--2002 are a rare resource as identified by the General Electric Medical Systems--2002 VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows General Electric Medical Systems--2002 to use them without interference from the competition.
- The distribution network of General Electric Medical Systems--2002 is a rare resource as identified by the VRIO Analysis of General Electric Medical Systems--2002. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of General Electric Medical Systems--2002. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of General Electric Medical Systems--2002 are costly to imitate as identified by the General Electric Medical Systems--2002 VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of General Electric Medical Systems--2002. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by General Electric Medical Systems--2002 provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of General Electric Medical Systems--2002 are also not costly to imitate as identified by the General Electric Medical Systems--2002 VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from General Electric Medical Systems--2002 by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of General Electric Medical Systems--2002 a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of General Electric Medical Systems--2002 are very difficult to imitate as identified by the VRIO Analysis of General Electric Medical Systems--2002. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of General Electric Medical Systems--2002 is also very costly to imitate by competition as identified by the General Electric Medical Systems--2002 VRIO Analysis. This has been developed over the years gradually by General Electric Medical Systems--2002. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of General Electric Medical Systems--2002 are organised to capture value as identified by the VRIO Analysis of General Electric Medical Systems--2002. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for General Electric Medical Systems--2002.
- The Patents of General Electric Medical Systems--2002 are not well organised as identified by the General Electric Medical Systems--2002 VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if General Electric Medical Systems--2002 starts selling patented products before the patents expire.
- The distribution network of General Electric Medical Systems--2002 is organised as identified by the VRIO Analysis of General Electric Medical Systems--2002. General Electric Medical Systems--2002 uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for General Electric Medical Systems--2002.
From the VRIO Analysis of General Electric Medical Systems--2002, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of General Electric Medical Systems--2002 is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Austin Steven
5.0
Without a fault in the content, structured sentence expression and genuine references were the confirmation of my satisfaction. Many thanks!
Noura Ali
5.0
The expert was very skilled and talented. I had a nice communication with him. Thanks!
Apolline Miklos
5.0
Their standard of paper was good because when I read it, there was no error in it. Thank you for helping me to improve my CGPA.
Kyril Joseph
5.0
Very happy with this service. It provided me with the best assistance that I ever came across. High-quality assignment at affordable fees. Thank you very much!
Next Articles
- Radiometer, 2003 Vrio Analysis
- Novartis' Sandoz: Between Generics And Pharma Vrio Analysis
- Zandu Pharmaceutical Works: The Takeover Bid (B) Vrio Analysis
- Eli Lilly 1998 (B): Emerging Global Organization Vrio Analysis
- Novo Industri Vrio Analysis
- Genzyme Corp.: Henri Termeer, President And CEO, Video Vrio Analysis
- Intuitive Surgical: Negotiating The Deal Vrio Analysis
- American Cyanamid (A): Boardroom Response To A Hostile Takeover Offer Vrio Analysis
- Learning From Collaboration: Knowledge And Networks In The Biotechnology And Pharmaceutical Industries Vrio Analysis
- Medical Technology Industry And Japan (A) Vrio Analysis
Previous Articles
- MDCM, Inc. (A): IT Strategy Synchronization Vrio Analysis
- Vioxx: Too Risky For Merck? Vrio Analysis
- Note On The Convergence Between Genomics & Information Technology Vrio Analysis
- Novo Industri (B) Vrio Analysis
- EMI And The CT Scanner (A), Spanish Version Vrio Analysis
- MBA Integrative Exercise: General Management, April 1998, Video Vrio Analysis
- American Cyanamid: Epilogue (C) Vrio Analysis
- Consumer Awareness Or Disease Mongering? GlaxoSmithKline And The Restless Legs Syndrome Vrio Analysis
- Price Fixing Vignettes Vrio Analysis
- EMI And The CT Scanner (B), Spanish Version Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!